Morocco to Acquire Russian Sputnik V Vaccine, Expanding COVID-19 Immunization Options

Morocco is preparing to acquire the Russian Sputnik V vaccine against Covid-19. An agreement has recently been signed between the Russian Direct Investment Fund and the Moroccan pharmaceutical company "Galenica".
In a statement to TASS, Artyom Tsinamdzgvrishvili, head of the Moscow trade mission, noted that the first batches of doses to be sent to Morocco could be enough to "vaccinate more than 20% of the Moroccan population". According to the business manager, "Galenica", the distribution networks of the Russian vaccine can ensure distribution not only in Morocco, but also "in other African countries".
Thanks to the free trade agreements signed by Morocco with the EU, the United States, Turkey and several Arab and African countries, the Moroccan manufacturing company could become "a hub for the distribution of the vaccine in other countries in the region," he specified. As the first country to develop the Covid vaccine, Russia has conducted clinical trials with Sputnik V which would be effective, according to the laboratory, at 92%.
Related Articles
-
Moroccan Beach Town Struggles with Tourism Management Despite Prime Location
7 June 2025
-
Agadir Bypass Highway Project Advances with New Geotechnical Study
7 June 2025
-
Rabat Demolitions Legal, Part of Long-Planned Development: Interior Minister
7 June 2025
-
Morocco Proposes New Law to Combat Used Car Fraud and Protect Buyers
7 June 2025
-
Morocco Blocks Extradition of Crypto Kidnapping Suspect to France
7 June 2025